4//SEC Filing
Wave Life Sciences Ltd. 4
Accession 0000899243-17-008992
$WVECIK 0001631574operating
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 3:34 PM ET
Size
8.0 KB
Accession
0000899243-17-008992
Insider Transaction Report
Form 4
Transactions
- Sale
Ordinary Shares
2017-03-29$24.91/sh−433,825$10,806,581→ 2,794,865 total(indirect: See Footnote)
Tanaka Masaharu
Director10% Owner
Transactions
- Sale
Ordinary Shares
2017-03-29$24.91/sh−433,825$10,806,581→ 2,794,865 total(indirect: See Footnote)
Footnotes (2)
- [F1]The aggregate purchase price for the 433,825 Ordinary Shares was 1,199,998,712 Japanese yen. The purchase price per share in Column 4 of Table I was calculated based on the aggregate purchase price divided by the number of Ordinary Shares sold. The purchase price per share is shown in U.S. dollars and was converted based on the currency exchange rate as of the transaction date, March 29, 2017, rounded to the nearest whole cent.
- [F2]Shares held by Kagoshima Shinsangyo Sousei Investment Limited Partnership ("KSS"). Masaharu Tanaka, a director of the Issuer, is the representative director of Kagoshima Development Co., Ltd., the general partner of KSS and may be deemed to beneficially own the reported securities. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), Mr. Tanaka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The filing of this Form 4 shall not be construed as an admission that Mr. Tanaka is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the reported securities.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeoperating
IncorporatedSingapore
Related Parties
1- filerCIK 0001631574
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 3:34 PM ET
- Size
- 8.0 KB